Natalie S. Callander

机构：University of Wisconsin System, University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, University of Wisconsin Health · ORCID：0000-0002-6975-1086

发表论文 449 篇 · 总被引 16635 次 · h-index 62

代表论文

NCCN Guidelines® Insights: Multiple Myeloma, Version 1.2025 (2025 · Journal of the National Comprehensive Cancer Network · 被引 55)
Multiple Myeloma, Version 5.2026, NCCN Clinical Practice Guidelines In Oncology (2026 · Journal of the National Comprehensive Cancer Network · 被引 21)
Phase 2 Registrational Study of Anitocabtagene Autoleucel for the Treatment of Patients with Relapsed and/or Refractory Multiple Myeloma: Preliminary Results from the IMMagine-1 Trial (2024 · Blood · 被引 21)
Optimal MRD-based end point to support response-adapted treatment cessation in newly diagnosed multiple myeloma (2025 · Blood · 被引 20)
MRD-Guided Sequential Therapy for Deep Response in Newly Diagnosed Multiple Myeloma (NDMM)- Master-2 Trial (2024 · Blood · 被引 17)
Phase 2 registrational study of anitocabtagene autoleucel for the treatment of patients with relapsed and/or refractory multiple myeloma: Updated results from iMMagine–1 (2025 · Blood · 被引 12)